Structure Therapeutics Inc ADR (NASDAQ:GPCR) price on Wednesday, April 30, rose 4.21% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $27.00.
A look at the stock’s price movement, the close in the last trading session was $25.91, moving within a range at $25.29 and $28.16. The beta value (5-Year monthly) was -1.458. Turning to its 52-week performance, $62.74 and $13.22 were the 52-week high and 52-week low respectively. Overall, GPCR moved 55.98% over the past month.
Structure Therapeutics Inc ADR’s market cap currently stands at around $1.55 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-26.
Turning to the stock’s technical picture we see that short term indicators suggest on average that GPCR is a 50% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend GPCR as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
GPCR’s current price about 36.85% and 30.59% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 73.82, while 7-day volatility ratio is 6.83% and 9.86% in the 30-day chart. Further, Structure Therapeutics Inc ADR (GPCR) has a beta value of -1.77, and an average true range (ATR) of 1.90. Analysts have given the company’s stock an average 52-week price target of $93, forecast between a low of $65 and high of $118. Looking at the price targets, the low is -140.74% off current price level while to achieve the yearly target high, price needs to move -337.04%. Nonetheless, investors will most likely welcome a -244.44% jump to $93 which is the analysts’ median price.
If we refocus on Structure Therapeutics Inc ADR (NASDAQ:GPCR), historical trading data shows that trading volumes averaged 1.56 over the past 10 days and 951.82K over the past 3 months. The company’s latest data on shares outstanding shows there are 57.29 million shares.
The 4.91% of Structure Therapeutics Inc ADR’s shares are in the hands of company insiders while institutional holders own 103.00% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 7.02 million on 2025-04-15, giving us a short ratio of 7.91. The data shows that as of 2025-04-15 short interest in Structure Therapeutics Inc ADR (GPCR) stood at 1453.0 of shares outstanding, with shares short falling to 7.04 million registered in 2025-03-14. Current price change has pushed the stock -0.44% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the GPCR stock continues to rise going into the next quarter.
